This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Sharp-PS® Featured in New Practitioner Product

GREEN BAY, Wis.—Integrative Therapeutics Inc. launched Phosphatidylserine with Sharp-PS® GREEN, a new product that contains Sharp-PS ®, from Enzymotec, Migdal HaEmeq, Israel. This is the second product launched with Sharp-PS ® within the health practitioner channel.

"Sharp-PS ® GREEN is the first of its kind soy allergen free phosphatidylerine (PS) ever launched to the market, it is no-GMO and was produced in an environmentally-conscious way," said Elzaphan Hotam, CEO of Enzymotec USA. "We see an ever-increasing interest in that product's source and the promise it holds, as there is a significant population which is cautious about soy and soy-derivatives."

Integrative Therapeutics Inc. manufactures and distributes proprietary, natural supplements exclusively to medical professionals. Its manufacturing facility is an organically certified and FDA-registered drug establishment.

Enzymotec is an Israeli biotech company, which operates in the pharmaceuticals, infant nutrition and nutraceutical segments. In the dietary supplement sector, Enzymotec is a supplier of high-end active ingredients to major retailers across the world. The company’s main mission is to provide branded companies with a better value proposition in three main health areas: cardiovascular disease (CVD) management, improving cognitive performance and balanced nutrition for babies and toddlers.

comments powered by Disqus